Applied Filters
COVID-19: patent procurement and licensing
Jonathan Tietz, Jason Mock, and Kristel Schorr of Foley & Lardner offer their thoughts on patent procurement and licensing for COVID-19-related technologies.
Broad Institute down (but not out) in the European fight over CRISPR IP
The search for clarity goes on as Broad gears up for another set of legal challenges, as Claire Irvine, partner at HGF, explains.
Global IP Exchange Europe: IP leaders’ investment priorities revealed
Ahead of the Global IP Exchange Europe on March 9-11 in Berlin, the event’s organisers surveyed senior executives to find out their IP, patent, trademark, and brand protection investment priorities for the next 6-12 months.
Conference preview: 12th Pharma & Biotech Patent Litigation
Secondary medical use case trends and research exemptions are just two issues set to be discussed at C5’s 12th Pharma & Biotech Patent Litigation meeting, on February 25–26 in Amsterdam.
Event preview: The election, Brexit, and the UPC
Ahead of the IQPC - Life Science IP conference in London, Kevin Mooney, chairman of the rules and procedure committee at the UPC, answers pressing questions on the IP landscape post-Brexit and the future of the Europe-wide patents court project.
Event preview: BIO-Europe returns to Hamburg
The special 25th anniversary BIO-Europe 2019 global life science partnering event will be held November 11–13, 2019, in Hamburg, Germany.
Event preview: Life Sciences IP Due Diligence summit
The Annual Summit on Life Sciences IP Due Diligence to be held on November 14 and 15 in Boston, MA, is a one-of-a-kind, interactive forum where diligence experts discuss best practices and strategies for executing a proper IP due diligence analysis for incumbent portfolios and those of potential targets.
Conference preview: LSX World Congress USA
LSX World Congress USA brings life sciences investment and partnering to Boston.
Brexit: The waiting game
As lawyers and industry prepare for a possible no-deal Brexit, the uncertainty surrounding its impact is palpable, as LSIPR’s Saman Javed discovers.
M&A: Year of the megadeal
LSIPR’s Sarah Morgan investigates the current state of play of M&A in the sector and predicts the next year of activity.
